KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Insulet (PODD) EBIT (2016 - 2025)

Historic EBIT for Insulet (PODD) over the last 17 years, with Q3 2025 value amounting to $117.7 million.

  • Insulet's EBIT rose 3359.82% to $117.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $436.9 million, marking a year-over-year increase of 4282.45%. This contributed to the annual value of $308.9 million for FY2024, which is 4040.91% up from last year.
  • Latest data reveals that Insulet reported EBIT of $117.7 million as of Q3 2025, which was up 3359.82% from $121.1 million recorded in Q2 2025.
  • Insulet's EBIT's 5-year high stood at $121.1 million during Q2 2025, with a 5-year trough of -$26.7 million in Q2 2022.
  • Its 5-year average for EBIT is $53.7 million, with a median of $49.7 million in 2021.
  • Per our database at Business Quant, Insulet's EBIT plummeted by 20152.09% in 2022 and then surged by 178965.52% in 2023.
  • Quarter analysis of 5 years shows Insulet's EBIT stood at $49.7 million in 2021, then crashed by 52.72% to $23.5 million in 2022, then skyrocketed by 352.77% to $106.4 million in 2023, then increased by 2.73% to $109.3 million in 2024, then increased by 7.69% to $117.7 million in 2025.
  • Its EBIT stands at $117.7 million for Q3 2025, versus $121.1 million for Q2 2025 and $88.8 million for Q1 2025.